HealthyWomen.org
Call Us: 1-877-986-9472 (toll-free)
      Spell Checker
Health Topics A-Z Sign up for Free e-Newsletters
Related Resources
 
Books (7)
News (2)
National Organizations (7)
Web Sites (11)
NWHRC Publications (6)
 
Health Topics A-Z
 
Table of Contents
 
 
Produced with financial support from TAP Pharmaceutical Products Inc.
 
EndoKnow.com
Health Topics A-ZText size: A A A May 13, 2008

References

Health Topics

Ryan, Kenneth, Ross Berkowitz, et al., eds. Kistner's Gynecology and Women's Health. 7th ed. St. Louis: Mosby, 1999. pp. 501-502.

"FDA Approves New Labels for Estrogen and Estrogen with Progestin Therapies for Postmenopausal Women Following Review of Women's Health Initiative Data." FDA News/Press Release. January 8, 2003. http://www.fda.gov. Accessed March 2003.

Grady D, Herrington D, Bittner V, et al, for the HERS Research Group. Heart and estrogen/progestin replacement study follow-up (HERS II): Part 1. Cardiovascular outcomes during 6.8 years of hormone therapy. JAMA 2002;288:49-57.

Hulley S, Furberg C, Barrett-Connor E, et al, for the HERS Research Group. Heart and estrogen/progestin replacement study follow-up (HERS II): Part 2. Non-cardiovascular outcomes during 6.8 years of hormone therapy. JAMA 2002;288:58-66.

Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333.

"Estrogen Plus Progestin Study Stopped Due to Increased Breast Cancer Risk, Lack of Overall Benefit." National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov. Updated July 9, 2002; accessed July 9, 2002.

"Women's Health Initiative," National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov. Updated July 9, 2002; accessed July 9, 2002.

"The Women's Health Initiative New Facts About: Estrogen/Progestin Therapy." National Heart, Lung and Blood Institute.http://www.nhlbi.nih.gov. Updated July 9, 2002; accessed July 9, 2002.

"Use of Hormone Replacement Therapy Questioned For Some Women: A Preliminary Response from The North American Menopause Society." http://www.nams.org. Updated July 9, 2002; accessed July 9, 2002.

Lacey, James V., et al. "Menopausal Hormone Replacement Therapy and Risk of Ovarian Cancer." JAMA 2002. Vol. 288:334-341.368-369.

Droegemuller, William. "Endometriosis and Adenomyosis: Etiology, Pathology, Diagnosis and Management," in Comprehensive Gynecology, 4th Ed., Stenchever, Droegemuller, Herbst, Michell (2001), p. 531-564.

"About DES (diethylstilboestrol)" Endometriosis.org. http://www.endometriosis.org. Dated 1999. Accessed August 2001.

"Endometriosis Family Study Identifies High Risk of Cancer and Autoimmune Diseases." Endometriosis Association. http://www.endometriosis.org. Dated 1999. Accessed August 2001.

Guidelines on the Treatment of Endometriosis: Update. American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin no. 11, Obstetrics and Gynecology, Dec. 1999.

Reproductive Conditions-Endometriosis. Veritas Medicine. http://www.veritasmedicine.com. Dated 2001. Accessed August 2001.

The Endometriosis Association. http://www.endometriosisassn.org. July 2005.

Endometriosis.org http://www.endometriosis.org. July 2005.

Endometriosis. Mayo Clinic. Available at: http://www.mayoclinic.com. Accessed October 2005.

Berkley KJ, Rapkin AJ, Papka RE. The pains of endometriosis. Science. 2005 Jun 10;308(5728):1587-9.

 
View References for this Health Topic Create Date: 2/1/02
Date Last Updated: 12/14/05
Review Date: 11/30/05
 
  Email this Page Email this Page
Sign up for Free E-Newsletters Print this Page Print this Page
ORDER PUBLICATIONS |  FREE E-NEWSLETTERS |  RSS FEEDS |  SITE MAP |  CONTACT US
National Women's Health Resource Center   157 Broad Street, Suite 106   Red Bank, NJ 07701   1-877-986-9472 (toll-free)